BUPILIN

Indications

• Infiltration anaesthesia in dentistry
• Nerve blocks for surgery
• Epidural anaesthesia
• Post-operative pain management

Dosage

Adults: Bolus doses of 1.5 mL/kg over 1 minute, with intervals of 5 minutes, and maximum cumulative doses should not exceed 12 mL/kg. For continuous infusion, the rate may

Mechanism of action

Bupivacaine hydrochloride acts by blocking voltage-gated sodium channels on the neuronal cell membrane, which inhibits the influx of sodium ions, leading to a decrease in depolarization and action potential generation. This mechanism results in reversible loss of sensation in the targeted area. The effect is dose-dependent and varies based on the route of administration.

Pharmacodynamics

Bupivacaine exhibits a high lipid solubility, which facilitates its action at the nerve membrane. The onset of action is typically within 10 to 20 minutes, with a duration of effect that can last from 2 to 8 hours, depending on the dosage and the method of administration. The drug provides effective analgesia, making it a preferred choice for procedures requiring prolonged pain relief. However, caution is advised as high concentrations can lead to systemic toxicity, primarily affecting the central nervous and cardiovascular systems.

Pharmacokinetics

Bupivacaine is rapidly absorbed following parenteral administration, with peak plasma concentrations occurring within 30 minutes to 2 hours. The drug is extensively metabolized in the liver by cytochrome P450 enzymes and excreted in the urine as metabolites. Its half-life ranges from 2.5 to 6 hours in healthy individuals, but it can be prolonged in patients with hepatic impairment. Due to its extensive protein binding (approximately 95%), the free fraction available for action is reduced in conditions affecting protein levels.

Contra-indications

• Hypersensitivity to bupivacaine or any of its components
• Application to damaged skin
• Severe hypertension
• Unstable cardiac rhythm

Adverse effects

• Face oedema
• Gingivitis
• Headache
• Nausea
• Abnormal sensation

Interactions

• Concurrent use of sympathomimetics may increase cardiovascular effects
• Adrenaline should be used with caution; total dose should not exceed 5 micrograms/kg
• Avoid using propofol as an alternative to lipid emulsion treatment

Precautions

• Use with caution in patients with hepatic impairment due to increased risk of toxicity
• Use with caution in patients with renal impairment
• Requires monitoring of blood pressure and ECG during administration
• Should only be administered by trained personnel experienced in its use

Pregnancy

Use only if potential benefit outweighs risk; no information available.

Breast-feeding

Avoid breastfeeding for 48 hours after administration.

Storage

Store at room temperature, away from light. Do not freeze.

Formulations

• Solution for injection cartridges
• Injectable preparation

Indications

• Regional anesthesia for surgical procedures
• Pain management in obstetric settings (e.g., epidural analgesia during labor)
• Postoperative analgesia
• Nerve blocks for pain control

Dosage

Children: Refer to the BNF for Children for specific dosing information in paediatric patients.

Adults: For infiltration anesthesia, the typical dose is 5 to 10 mL of a 0.25% to 0.5% solution. For epidural anesthesia, a dose of 10 to 20 mL of a 0.25% to 0.5% solution may be used, depending on the procedure.

Mechanism of action

Bupivacaine acts by inhibiting voltage-gated sodium channels in the neuronal cell membrane. This inhibition prevents the initiation and propagation of action potentials, leading to a reversible loss of sensation in the area supplied by the affected nerves. It predominantly affects small unmyelinated fibers, which are responsible for pain and temperature sensation.

Pharmacodynamics

The onset of action for bupivacaine is dose-dependent, with effects typically observed within 10 to 30 minutes after administration, depending on the route of administration. The duration of action can last from 2 to 8 hours, with longer durations noted for higher doses or when used in conjunction with vasoconstrictors. Bupivacaine is more potent than lidocaine and provides a longer duration of anesthesia.

Pharmacokinetics

Bupivacaine is well-absorbed after injection, with peak plasma concentrations occurring within 30 minutes. It is metabolized primarily in the liver by cytochrome P450 enzymes, and its metabolites are excreted in the urine. The elimination half-life ranges from 2.5 to 6 hours, depending on the route of administration and patient-specific factors.

Contra-indications

• Hypersensitivity to bupivacaine or any component of the formulation
• Severe heart block
• Severe hepatic impairment
• Uncontrolled hypotension

Adverse effects

• Cardiovascular collapse
• Hypotension
• Bradycardia
• Nausea
• Vomiting
• Dizziness
• Headache
• Numbness
• Paresthesia
• Tremors

Interactions

• Concurrent use with other local anesthetics may increase the risk of toxicity
• Caution advised when used with agents that can affect the cardiovascular system

Precautions

• Use with caution in patients with cardiovascular disease
• Monitor for signs of systemic toxicity, particularly in high doses or accidental intravascular injection
• Ensure resuscitation equipment and trained personnel are available during administration

Pregnancy

Bupivacaine can be used during pregnancy when the potential benefits justify the risks. Consult relevant clinical guidelines.

Breast-feeding

Bupivacaine is excreted in breast milk. Caution is advised when administering to nursing mothers.

Storage

Store at room temperature, away from light and moisture. Do not freeze.

Formulations

• Injection solution
• Epidural solution
• Nerve block solution

Indications

• Adjustment of pH in pharmaceutical formulations
• Facilitation of drug absorption
• Used in sterile preparations

Dosage

Children: Refer to specific product guidelines for dosing information, as hydrochloric acid is typically used in a controlled setting based on formulation requirements.

Adults: Refer to specific product guidelines for dosing information, as hydrochloric acid is typically used in a controlled setting based on formulation requirements.

Mechanism of action

Hydrochloric acid dissociates in aqueous solution to release hydrogen ions (H+), leading to a decrease in pH. This acidic environment promotes the activation of pepsinogen to pepsin, an enzyme essential for protein digestion. Additionally, the acidity aids in the absorption of certain minerals and drugs that require an acidic environment for optimal bioavailability.

Pharmacodynamics

The primary pharmacodynamic action of hydrochloric acid is the maintenance of gastric acidity, which is essential for normal digestive processes. The acidic environment helps in denaturing proteins, activating digestive enzymes, and providing a barrier against pathogenic microorganisms. Its effects can influence the absorption and efficacy of various medications, particularly those that are pH-dependent.

Pharmacokinetics

Hydrochloric acid does not undergo significant systemic absorption when used in its normal contexts, as it acts locally within the gastrointestinal tract. The amount of hydrochloric acid produced by the stomach varies with food intake and physiological needs. It is secreted by parietal cells in the gastric mucosa, and its secretion is regulated by neural, hormonal, and local factors. The half-life of hydrochloric acid is not applicable as it is continuously produced and neutralized within the gastrointestinal tract.

Contra-indications

• Hypersensitivity to hydrochloric acid or any of its components
• Severe renal impairment
• Active gastrointestinal bleeding

Adverse effects

• Abdominal pain
• Diarrhea
• Nausea
• Vomiting
• Esophageal irritation
• Gastric mucosal irritation
• Electrolyte imbalances

Interactions

• May interact with alkaline substances, potentially neutralizing hydrochloric acid
• Caution with antacids as they may affect the efficacy of hydrochloric acid

Precautions

• Use with caution in patients with a history of gastritis or gastric ulcers
• Monitor electrolytes in prolonged use
• Use cautiously in patients with respiratory conditions due to potential aspiration risks

Pregnancy

Hydrochloric acid is classified as a category C drug. Use during pregnancy only if clearly needed and the potential benefits justify the risks to the fetus.

Breast-feeding

There is limited data on the excretion of hydrochloric acid in human milk. Use with caution during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight and heat. Ensure the container is tightly closed.

Formulations

• Oral solutions
• Injectable forms
• Tablets

Dosage

Children: Refer to specific guidelines for pediatric dosing; consult the BNF for Children for accurate dosage information.

Adults: Refer to specific guidelines for use; dosage may vary based on the context of use.

Mechanism of action

Hydroxide ions act primarily as bases, neutralizing acids to form water and salts. They participate in various biochemical pathways, including selenium metabolism and the degradation of reactive oxygen species. Hydroxide can influence enzyme activity and stability by altering the pH of the environment, thereby affecting metabolic reactions.

Pharmacodynamics

Hydroxide ions can impact biological processes by changing the local pH, which influences enzyme activity, ion transport, and the solubility of other compounds. Their ability to neutralize acids can help regulate physiological pH, contributing to homeostasis in living organisms.

Pharmacokinetics

As an inorganic ion, hydroxide does not undergo traditional pharmacokinetic processes like absorption, distribution, metabolism, or excretion. Instead, it is rapidly equilibrated in biological fluids and participates in acid-base reactions, having immediate effects on the local environment.

Pregnancy

There is limited information regarding the use of hydroxide during pregnancy. Consult a healthcare professional for advice.

Breast-feeding

Limited data is available on the excretion of hydroxide in breast milk. Consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Pain management
• Vaccination
• Antibiotic therapy
• Hormonal therapies
• Anesthesia
• Nutritional support
• Chemotherapy

Dosage

Children: Refer to specific drug guidelines for paediatric dosing, as it requires careful consideration of weight and age.

Adults: Refer to specific drug guidelines for adult dosing, as it varies widely depending on the medication and clinical condition.

Mechanism of action

The mechanism of action of injected drugs varies widely based on the specific medication being administered. Generally, injected drugs enter the bloodstream directly, allowing them to circulate rapidly throughout the body. For instance, antibiotics may work by inhibiting bacterial cell wall synthesis, while analgesics may modulate pain pathways in the central nervous system. Each drug has unique pathways through which it achieves its therapeutic effects.

Pharmacodynamics

Pharmacodynamics refers to the effects of drugs on the body and their mechanisms of action. For injectable medications, effects can be immediate or delayed, depending on the drug's formulation and route of administration. Factors influencing pharmacodynamics include receptor affinity, drug concentration, and the presence of other substances that may enhance or inhibit the drug's effects. For example, some injectable drugs may require specific receptors to exert their effects, while others may have a broader range of action.

Pharmacokinetics

Pharmacokinetics involves the absorption, distribution, metabolism, and excretion (ADME) of injected drugs. After administration, drugs are rapidly absorbed into the bloodstream, leading to quick therapeutic effects. The distribution depends on factors such as blood flow, tissue permeability, and protein binding. Drugs are metabolized primarily in the liver and excreted through the kidneys or bile. The pharmacokinetic profile can vary widely based on the drug's chemical nature, dosage, and individual patient factors.

Pregnancy

Safety during pregnancy depends on the specific injection and its active ingredients. It is essential to consult a healthcare professional for guidance.

Breast-feeding

The safety of injections during breastfeeding varies by the specific medication. It is recommended to seek advice from a healthcare provider.

Storage

Store injections as per manufacturer's guidelines, usually in a cool, dry place away from direct sunlight. Some may require refrigeration.

Dosage

Children: Refer to specific drug formulations for dosage.

Adults: Refer to specific drug formulations for dosage.

Pregnancy

Safety in pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Consult a healthcare provider before use. Potential risks and benefits should be considered.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Hormone replacement therapy
• Pain management
• Chronic disease management
• Certain psychiatric conditions
• Hormonal imbalance

Dosage

Children: Refer to specific product information and guidelines, as dosing will vary based on the active ingredient and clinical indication.

Adults: Refer to specific product information and guidelines, as dosing will vary based on the active ingredient and clinical indication.

Mechanism of action

Pellets can contain various active pharmaceutical ingredients that may act through different mechanisms. For example, hormone pellets release hormones such as testosterone or estrogen into the bloodstream, where they bind to specific receptors to exert their physiological effects. The controlled release mechanism allows for a gradual increase in hormone levels, mimicking the body's natural secretion patterns.

Pharmacodynamics

The pharmacodynamic effects of pellets depend on the active ingredients contained within them. For hormone pellets, the effects can include modulation of reproductive processes, alleviation of menopausal symptoms, or enhancement of muscle mass and strength in the case of testosterone. The controlled release mechanism helps maintain therapeutic levels of the drug in the plasma, which can lead to more stable and effective treatment outcomes.

Pharmacokinetics

The pharmacokinetics of pellets vary based on the specific drug formulation. Generally, after administration, pellets dissolve or disintegrate, allowing the active ingredient to be absorbed into the bloodstream. The rate of absorption and the time to peak plasma concentration will depend on the pellet's composition, the solubility of the drug, and the physiological conditions of the gastrointestinal tract or the application site. The half-life of the drug will also influence the dosing schedule and the duration of action.

Pregnancy

Safety in pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether this drug is excreted in human milk. Caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.